Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
9,49 USD | -0,11 % | -7,68 % | -37,19 % |
Kurzporträt
Mitarbeiterzahl: 839
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Spinal Fusion Technology Products for the Treatment of Spinal Disorders
100,0
%
| 351 | 100,0 % | 482 | 100,0 % | +37,45 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
92,3
%
| 327 | 93,1 % | 445 | 92,3 % | +36,32 % |
International
7,7
%
| 24 | 6,9 % | 37 | 7,7 % | +52,71 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Patrick Miles
CEO | Chief Executive Officer | 58 | 02.10.17 |
J. Koning
DFI | Director of Finance/CFO | 51 | 19.04.21 |
Scott Lish
COO | Chief Operating Officer | 43 | 01.10.17 |
Luiz Pimenta
CTO | Chief Tech/Sci/R&D Officer | - | 08.03.18 |
Tina Jacobsen
IRC | Investor Relations Contact | - | - |
Eric Dasso
PRN | Corporate Officer/Principal | 51 | 01.08.19 |
David Sponsel
SAM | Sales & Marketing | 45 | 01.05.18 |
Joe Walland
PRN | Corporate Officer/Principal | 46 | 01.12.20 |
General Counsel | 50 | 19.07.23 | |
Ali Shorooghi
SAM | Sales & Marketing | 38 | 01.11.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jeffrey Rydin
BRD | Director/Board Member | 57 | 15.06.17 |
David Mowry
BRD | Director/Board Member | 61 | 08.02.17 |
James Tullis
BRD | Director/Board Member | 77 | 08.03.18 |
Ward Woods
BRD | Director/Board Member | 81 | 19.10.17 |
Evan Bakst
BRD | Director/Board Member | 57 | 08.03.18 |
Patrick Miles
CEO | Chief Executive Officer | 58 | 02.10.17 |
Director/Board Member | 70 | 04.03.05 | |
David Pelizzon
BRD | Director/Board Member | 68 | 17.06.20 |
Director/Board Member | 45 | 02.10.17 | |
Director/Board Member | 53 | 12.08.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 144 218 000 | 102 353 364 ( 70,97 %) | 1 808 000 ( 1,254 %) | 69,37 % |
Aktie B | 0 | 3 319 000 | 0 | 0 |
Unternehmenskontakt
Alphatec Holdings, Inc.
1950 Camino Vida Roble
92008, Carlsbad
+760 431 9286
http://www.alphatecspine.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Alphatec Spine, Inc.
Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Alphatec Spine, Inc. is focused on the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders, with a focus on treating condition affecting the aging spine. The firms product portfolio and pipeline include spinal disorder products and systems. The company was founded in 1990 and is headquartered in Carlsbad, CA. |
Medical Specialties
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-37,19 % | 1,33 Mrd. | |
-6,03 % | 180 Mrd. | |
+1,08 % | 109 Mrd. | |
-2,19 % | 68,93 Mrd. | |
-5,98 % | 46,41 Mrd. | |
+12,31 % | 45,43 Mrd. | |
+7,66 % | 43,26 Mrd. | |
+15,98 % | 30,05 Mrd. | |
+16,25 % | 25,19 Mrd. | |
-9,57 % | 23,19 Mrd. |
- Börse
- Aktien
- A2AP5V Aktie
- Unternehmen Alphatec Holdings, Inc.